Methods: Of the 559 patients studied, 40 had CPPE. All underwent PF analysis: pH, glucose (PFGLUC), LD (PFLD), PFIL-1β and PFIL-8, and PF/serum ratios (PF/ SIL-1β and PF/SIL-8).
Parapneumonic pleural effusion (PPE) is defined as the accumulation of pleural fluid (PF) associated with exudative pneumonia, lung abscess, or bronchiectasis. [1] [2] [3] Thirty percent of patients with pneumonia develop pleural effusion (PE). 1, [4] [5] [6] [7] Normally, this uncomplicated PPE (UCPPE) is resolved with standard antibiotic treatment, but 2% to 30% evolve into a complicated PPE (CPPE), which requires the placement of an intercostal catheter or even surgery for resolution. 1, 4, 8 Delay in the initiation of appropriate therapy for these effusions can cause a substantial increase in morbidity.
However, no clinical or radiographic findings provide sufficient diagnostic certainty to establish the need for pleural drainage in patients with PPE. 9, 10 Observing intrapleural pus or nonpurulent fluid with positive Gram stain is an indication for immediate drainage of PF but has low diagnostic sensitivity. The measurement of pH (<7.20), glucose (<60 mg/dL), and Upon completion of this activity you will be able to:
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lactate dehydrogenase (LD; >1,000 U/L) in the PF has been suggested to help make this decision. 6, [11] [12] [13] When bacterial infection occurs, increased vascular permeability and local release of inflammatory mediators may result in a pleural cavity reaction, consisting of fluid accumulation with a high number of inflammatory cells. 14 Interleukin-1β (IL-1β) and IL-8 are powerful mediators, with a key role in the inflammation involving the pathogenesis of infectious pleural effusions. [15] [16] [17] As has been shown for pneumococcal infections, 18 bacterial cell wall components bind to leukocytes and possibly mesothelial cells, eliciting the production of IL-1β, IL-6, IL-8, and tumor necrosis factor-α.
Our working hypothesis is that the measurement of the mediators involved in the inflammatory mechanism of PPE may be useful in the diagnosis of CPPE. The aim of this study is to evaluate the utility of IL-1 and IL-8 for the early diagnosis of CPPE and for anticipating appropriate therapeutic measures to avoid the consequences this pleuritis can produce.
Materials and Methods
We studied 559 patients with PE who had attended our hospital in the past 5 years. Patients were classified into six groups according to the final diagnosis, based on preestablished criteria 19 ❚Table 1❚: CPPE (n = 40, including 23 empyemas), UCPPE (n = 91), tuberculosis (TB; n = 43), neoplasms (NEO; n = 148), miscellaneous (MIS; n = 120), and transudates (TRANS; n = 117). Complicated parapneumonic effusion was established by one or more of the following criteria: purulent fluid on macroscopic examination, positive Gram stain and/or micro-organism growth in culture, or observation of septa and/ or partitions in the previous thoracic ultrasound thoracentesis in association with pneumonia. In such cases, a chest tube was placed, just as when the pH was less than 7.20 (in any PF measurements). Patients were excluded from the study when pH in the PF could not be determined (CPPE, n = 14; UCPPE, n = 26; TB, n = 23; NEO, n = 60; MIS, n = 48; and TRANS, n = 42). All patients had PF and serum analysis of LD (PFLD), glucose (PFGLUC), IL-1 (PFIL-1β), and IL-8 (PFIL-8). The pH was determined only in PF. The study was approved by the Galician Research Ethics Committee. All patients gave informed consent prior to undergoing thoracocentesis.
Samples
Withdrawal of PF by thoracentesis and peripheral blood by venipuncture was performed during fasting. Both samples were collected into BD Vacutainer tubes (Becton Dickinson, Plymouth, England), with EDTA for cell counts and a plain tube for processing the supernatant after centrifugation at 2,500g for 10 minutes.
Cell Counts
Total WBC and differential counts were performed on the PF and peripheral blood samples by using the ADVIA 2120 Hematology analyzer (Siemens Healthcare Diagnostics, Tarrytown, NY). The PF differential count was performed by using a conventional optical microscope.
Interleukin Determinations
IL-8 and IL-1β were measured by using a solid-phase, twosite chemiluminescent immunometric assay (IMMULITE/ IMMULITE IL-8 and IMMULITE/IMMULITE IL-1β) on an IMMULITE 1000 Analyzer (Siemens Healthcare Diagnostics, Llanberis, Gwynedd, Wales). Intra-assay precision (two levels) was 3.8% and 4.1% for IL-8 and 3.1% and 4.9% for IL-1; between-assay precision was 5.5% and 7.7% for IL-8 and 5.1% and 9.1% for IL-1β.
Glucose and LD Measurements
The determination of glucose and LD was performed on the ADVIA 2400 (Siemens Healthcare Diagnostics) by using the ADVIA Chemistry Glucose Hexokinase 3 Concentrated Reagents and the ADVIA LDPL reagent based on the extinction coefficient of NADH, respectively.
pH Measurement
Measurement of pH was performed by using the RAPIDLab 1200 blood gas system (Siemens Healthcare Diagnostics).
Statistical Analysis
Normal distribution was checked by the D'AgostinoPearson test. Variance analysis was used to analyze the differences between the various populations. The correlation between the different parameters was determined by the Spearman test. The receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficiency of the different parameters studied, based on obtaining the best differential diagnosis, by using the statistical program MedCalc Software version 12.7.1.0 (MedCalc Software, Ostend, Belgium).
Results
❚Table 2❚ shows the results obtained in the different diagnostic groups and a comparison with the group of patients with CPPE. PFLD, PFIL-1β, PFIL-8, and pH levels, as well as total leukocyte and polymorphonuclear percentage, showed a statistically significant difference (P < .001) between the CPPE and the other groups; in all cases, the CPPE group showed elevations except in the pH ❚Figure 1❚. PFGLUC levels in the CPPE group showed no significant differences from the other effusions. The PF/ serum ratios for IL-1 (PF/SIL-1β) and IL-8 (PF/SIL-8) were also significantly higher in patients with CPPE (P < .001) ( Table 2) .
❚Table 3❚ shows the area under the curve (AUC) of all the parameters studied, as well as their diagnostic yield with cutoffs chosen for each. The diagnostic criterion showing the best AUC was the combination of PF/ SIL-8 and PFIL-1β (0.906), with a statistically significant difference (P < .05) compared with PFGLUC (0.768) and the classic criterion of pH and PFGLUC or PFLD (0.826) ❚Figure 2❚, but not with respect to these parameters individually. The combination of PF/SIL-8 and PFIL-1β (cutoffs >5.73 and >9.14 pg/mL, respectively) was significantly more sensitive (72.7%) than the combination of pH and PFGLUC or PFLD (64.9%) (P < .05) and more specific (97.9%) than the rest of the parameters used (P < .05), except for the combination of pH and PFLD or PFGLUC (96.9%).
All analytes studied in PF showed a statistically significant correlation among them (ranging between P < .001 and P < .05) ❚Table 4❚, except between PFGLUC and PFIL-1β (not significant). In the case of pH and PFGLUC, correlation with respect to the other parameters was negative. 
Discussion
Our results demonstrate that PFIL-1β and PFIL-8 may be useful markers in the diagnosis of the CPPE since they accumulate in the pleural cavity and are released by a large number of inflammatory cells.
PPE can follow a developmental course through different phases (exudative, fibrinopurulent, and organizational) in a continuous process, and its progression depends on the rapid introduction of appropriate antibiotic therapy. 12, 20, 21 In the absence of treatment, the condition may progress, requiring placement of a chest tube or pleural decortication. 21 The diagnosis of these patients is not easy. Symptoms may not correspond to the stages that lead from UCPPE to CPPE, 4,5 and X-ray and ultrasound tests may not show the presence of septa and walls in the pleural space, either because these have not yet been established or because the interstitial inflammatory process may mask parapneumonic lesions. 20, 22 In addition, the waiting time for microbiological testing is prolonged, and the cultures may be negative in a high percentage of cases. [22] [23] [24] The aim of the study was to assess the yield of IL-1β and IL-8 in the diagnosis of an early form of CPPE, and so the results of the first thoracentesis were used. The parameters used up to now to diagnose CPPE may not be fast enough to detect these effusions since their alteration is due to an increased metabolism of the cells present in the PF (which leads to a decreased level of glucose), acidosis (pH decline), and destruction of cells involved in this process (increased LD). All of this requires progression of the effusion, which, together with the time delay of the cultures and their low positivity, can result in the establishment of complications of CPPE, leading to its diagnosis. 12, [22] [23] [24] [25] Different scientific societies recommend the following guidelines for PF in the diagnosis of CPPE: pH (<7.20) and glucose (<60 mg/dL) or pH (<7.20), glucose (<40 mg/ dL), and LD (>1,000 U/L). 24, 26 However, it has been shown that while both models have a high specificity, sensitivity is moderate, and their absence does not rule out a CPPE. 27 Measurement of pH in PF is the parameter that presented the greater specificity individually (95.4%; Table 3 ), although with a low sensitivity (72.5%) (Figure 1 ). Its use is not without criticism. Numerous studies have shown multiple interferences that can affect its measurement. Increased acidification may result from the presence of traces of the local anesthetic used in thoracentesis or the heparin used in the syringe for the sample extraction. Alkalinization has also been described due to the delay in sending samples to the laboratory or the presence of air bubbles in the heparinized syringe. 1, 24, 28, 29 In addition, some laboratories reject samples suspected of having empyema because these purulent fluids, with abundant cellular debris, might damage gas analysis systems, 29, 30 which provide the only method that guarantees correct measurement of pH. 5, 6, 31 In fact, in our study, 29% of empyemas lacked measurement of pH, having had problems with the sample, compared with 17% of other UCPPEs. The AUC of the pH was 0.884, slightly lower than that reported in a classic meta-analysis (0.92). 28 The study of PFLD also has good diagnostic efficiency (AUC, 0.898; sensitivity, 80%; specificity, 90.1%, for a cutoff of >1,000 IU/L). Excluding the group of transudates, easily distinguishable from CPPE in clinical practice, 11% of the non-CPPE effusions had values above the cutoff point ( Figure  1 ). This AUC was slightly higher than that described in the meta-analysis (0.82). 28 PFGLUC values, like those of the pH, may be affected by the delay in delivery of the samples in the laboratory, especially those with high cellularity, since glycolysis continues until centrifugation and separation. In our study, PFGLUC presented a low diagnostic yield, with an AUC of 0.768, with no statistically significant differences between any diagnostic group and CPPE (Table 2 ). This AUC is lower than that described previously (0.84). 28 The joint application of these three parameters (pH <7.2 with a PFGLUC <60 mg/dL or PFLD >1,000 IU/L) provided an AUC of 0.826 (sensitivity, 64.9%; specificity, 96.9%; positive likelihood ratio, 34.59; negative likelihood ratio, 0.66).
The total count and percentage of nucleated cells showed, as in other studies, 6, 20, 23, 30, 32 high dispersion of values, and 40% of empyemas had values less than 10,000 cells/mm 3 . This may occur for the following reasons: the effusion is multiloculated, with thoracentesis performed in a less affected lobule, to which the sample shows clotting not detectable before counting, or the appearance of the liquid effusion is purulent, but its contents may consist mainly of cell debris that is not detectable by cell counting. For these reasons, it does not appear that the diagnosis of the CPPE should be based on these parameters.
Due to the problems with the parameters mentioned in the diagnosis of CPPE, we have sought alternatives that reflect the inflammatory reactions occurring in the pleural space in PPE. Thus, both PFIL-1β and PFIL-8 may be elevated in these patients, resulting from increased vascular permeability, accumulation of inflammatory cells, and subsequent release of these mediators in the pleural space. These interleukins contribute to increased recruitment of neutrophils into the pleural space and the production and secretion of new interleukins. 3, 7, 24, [32] [33] [34] PFIL-1β and PFIL-8 levels, as well as their respective PF/ serum ratios, are significantly higher in CPPE ( Figure 1 , Table  2 ), with a good discriminative power, although individually they may not improve the results obtained with PFLD. In the case of PFIL-8, the AUC is similar to previous studies published by other authors. 13 To improve individual results, we combined performance parameters that showed better AUC (PF/SIL-8 and PFIL-1β). The AUC thus obtained was 0.906 (sensitivity, 72.7%; specificity, 97.9%), greater than that achieved with the combination of pH, glucose, and LD (AUC, 0.826; sensitivity, 64.9%) but significantly worse than the combination of PF/SIL-8 and PFIL-1β (specificity, 96.9%) for the diagnosis of CPPE (Table 3, Figure 2 ). Although these differences are small, the serious complications that a mistreated CPPE has for the patient make them valuable from a clinical point of view.
The main limitation of our study is its retrospective nature. In addition, the CPPE group was relatively small (40 cases) and a high percentage of empyemas (29%) lacked measurement of pH because of problems with the sample (compared with 17% of other UCPPEs). Finally, a common limitation of these studies is that there is no "gold standard" for judging whether the indication for chest drainage from the clinician is correct. In many cases, the diagnosis of CPPE is subjectively set by the clinician based on his or her experience and the biochemical, radiologic, and microbiologic data. However, patients with PPE who have poor prognostic variables in the PF (pleural acidosis, low glucose, and positive bacterial cultures) can progress satisfactorily toward resolution only with the appropriate antibiotic treatment without requiring a chest drain. 24 That is, using the classic parameters (pH, glucose, or culture) as part of the means of establishing the diagnosis of CPPE increases estimated diagnostic accuracy compared with the new parameters.
In summary, our results demonstrate that the measurements of IL-1β and IL-8 in pleural fluid may be useful in the diagnosis of CPPE by informing us early of the need to conduct more aggressive treatment in these patients. Further studies are warranted, with designs in which the parameters to be studied are not penalized with respect to those currently established, confirming the role these interleukins can play in diagnosing such pleuritis. 
